Safety of contrast-enhanced ultrasound using microbubbles in human pregnancy: A scoping review.
Sophie Dassen, Loes Monen, Guid Oei...
https://pubmed.ncbi.nlm.nih.gov/38914129/Actively Recruiting
Led by Maxima Medical Center · Updated on 2026-02-19
5
Participants Needed
1
Research Sites
4 weeks
Total Duration
This research focuses on pregnant individuals at term to study the blood vessels called uterine spiral arteries that develop within the uterine wall during pregnancy. These arteries undergo important changes to increase blood flow to the placenta, supporting the babys growth. Problems with this process can lead to complications like pre-eclampsia or restricted fetal growth. The study aims to use contrast-enhanced ultrasound CEUS to visualize these spiral arteries after delivery, which has not been possible before, and to monitor uterine artery blood flow changes during late pregnancy, labor, and postpartum. Participants will receive contrast-enhanced ultrasound imaging within four hours after giving birth to check if the spiral arteries remain visible and to assess how well CEUS works for this purpose. Additionally, Doppler ultrasound measurements of the uterine arteries will be taken at three times after 37 weeks of pregnancy before delivery, during labor, and within four hours after delivery. This approach combines CEUS and Doppler imaging to better understand blood vessel changes around the time of birth. During the study, participants will have ultrasound exams to measure blood flow characteristics like resistance index, pulsatility index, and systolicdiastolic ratio in the uterine arteries. Researchers will compare these Doppler results with CEUS findings to see how the arteries behave before, during, and after delivery. The main outcomes include whether spiral arteries can be detected postpartum with CEUS and the feasibility of this imaging method within four hours after birth. The study is planned to start in December 2025 and continue until July 2026.
CONDITIONS
PlaCEUS: Feasibility Study of Contrast-enhanced Ultrasound to Visualize Maternal Uterine Spiral Arteries Postpartum.
E
Eveline Dekker, Drs
L
Loes Monen, Dr.
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Maxima Medical Center
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - From after 37 weeks gestation through delivery day
Participants undergo Doppler ultrasound assessments of the uterine arteries before delivery and during labor to evaluate blood flow and vascular resistance.
2 visits (in-person): one before delivery and one during labor
Duration - Within 4 hours postpartum
Participants receive contrast-enhanced ultrasound imaging within 4 hours postpartum to visualize maternal uterine spiral arteries using SonoVue contrast agents.
1 visit (in-person) postpartum
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
DIAGNOSTIC
Number of Arms
1
Have more questions? Get in touch with our team for quick support
Sophie Dassen, Loes Monen, Guid Oei...
https://pubmed.ncbi.nlm.nih.gov/38914129/Qiuyang Li, Kaixiu Yang, Yongjiao Ji...
https://pubmed.ncbi.nlm.nih.gov/36357252/V H J Roberts, T K Morgan, P Bednarek...
https://pubmed.ncbi.nlm.nih.gov/29136193/S L Collins, J S Birks, G N Stevenson...
https://pubmed.ncbi.nlm.nih.gov/22102536/M Claudon, D Cosgrove, T Albrecht...
https://pubmed.ncbi.nlm.nih.gov/18270887/Maxima Medical Center
Lead Sponsor